Literature DB >> 34508234

Abbreviating DAPT reduces the risk of bleeding.

Gregory B Lim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34508234     DOI： 10.1038/s41569-021-00619-z

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  3 in total

1.  Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.

Authors:  Marco Valgimigli; Enrico Frigoli; Dik Heg; Jan Tijssen; Peter Jüni; Pascal Vranckx; Yukio Ozaki; Marie-Claude Morice; Bernard Chevalier; Yoshinobu Onuma; Stephan Windecker; Pim A L Tonino; Marco Roffi; Maciej Lesiak; Felix Mahfoud; Jozef Bartunek; David Hildick-Smith; Antonio Colombo; Goran Stanković; Andrés Iñiguez; Carl Schultz; Ran Kornowski; Paul J L Ong; Mirvat Alasnag; Alfredo E Rodriguez; Aris Moschovitis; Peep Laanmets; Michael Donahue; Sergio Leonardi; Pieter C Smits
Journal:  N Engl J Med       Date:  2021-08-28       Impact factor: 91.245

Review 2.  Bleeding avoidance strategies in percutaneous coronary intervention.

Authors:  Davide Capodanno; Deepak L Bhatt; C Michael Gibson; Stefan James; Takeshi Kimura; Roxana Mehran; Sunil V Rao; Philippe Gabriel Steg; Philip Urban; Marco Valgimigli; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2021-08-23       Impact factor: 32.419

3.  Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial.

Authors:  Pieter C Smits; Enrico Frigoli; Jan Tijssen; Peter Jüni; Pascal Vranckx; Yukio Ozaki; Marie-Claude Morice; Bernard Chevalier; Yoshinobu Onuma; Stephan Windecker; Pim A L Tonino; Marco Roffi; Maciej Lesiak; Felix Mahfoud; Jozef Bartunek; David Hildick-Smith; Antonio Colombo; Goran Stankovic; Andrés Iñiguez; Carl Schultz; Ran Kornowski; Paul J L Ong; Mirvat Alasnag; Alfredo E Rodriguez; Aris Moschovitis; Peep Laanmets; Dik Heg; Marco Valgimigli
Journal:  Circulation       Date:  2021-08-29       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.